多模态影像与液体活检评估局部晚期直肠癌治疗反应的前瞻性可行性研究
17例局部晚期直肠癌患者在新辅助治疗前后接受PET-MRI和CT灌注检查,其中12例加做液体活检(循环肿瘤细胞和细胞外囊泡),以改良Ryan肿瘤消退分级为参考标准;血液标志物联合CT灌注参数(平均通过时间、K-trans、渗透表面积乘积)预测治疗反应的模型最强(p<0.01),PET-MRI的ADC值未能提供显著预测模型。
要点
- 血液标志物联合CT灌注参数(平均通过时间、K-trans、渗透表面积乘积)预测治疗反应的模型最强(p<0.01)。
- MRI衍生的ADC值未能提供显著的治疗反应预测模型。
- PET的SUV测量联合CT灌注衍生的K-trans模型预测反应仅达边缘显著(p=0.057)。
核心结论
- CT灌注参数联合液体活检的模型比PET-MRI、单独CT灌注或单独液体活检更准确地预测肿瘤治疗反应;液体活检可为CT灌注等功能影像提供补充信息,作者建议在更大样本量的试验中进一步探索。
研究设计与样本
- 前瞻性可行性研究,纳入17例局部晚期直肠癌患者,所有患者在新辅助治疗前后接受混合PET-MRI和CT灌注检查,其中12例同时接受液体活检(采用Cell Search System分析循环肿瘤细胞和细胞外囊泡,包括细胞碎片和微粒);以改良Ryan肿瘤消退分级系统作为组织病理学参考标准。
诊断标准与关键数值
- 17例中14例按改良Ryan肿瘤消退分级评为非反应者,3例评为反应者。
局限性
- 作者在结论中提出液体活检应在更大样本量的试验中进一步探索。
- 17例中仅12例接受了液体活检。
- PET的SUV联合CT灌注K-trans预测反应的模型仅达边缘显著(p=0.057)。
- MRI衍生的ADC值未能提供显著的治疗反应预测模型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Colorectal cancer is a commonly encountered disease that poses several diagnostic and therapeutic challenges. The inherent heterogeneity of tumor biology and propensity to relapse despite "curative" resection pose significant challenges with regard to response assessment. Although MR imaging already plays a key role in primary staging of patients with rectal carcinoma, its reliability in restaging after neoadjuvant therapy is debatable (Van der broek et al. in Dis Colon Rectum 60(3):274-283, 2017). Therefore, there is significant interest in developing additional methods which may improve diagnostic accuracy. This study aims to evaluate the role of multimodality imaging and liquid biopsy in therapeutic response assessment.
METHODS: Seventeen patients were enrolled into the study over a span of 24 months. All underwent hybrid PET-MRI and CT-perfusion (CT-P), prior to and following neoadjuvant therapy for locally advanced rectal carcinoma. Twelve of the 17 patients also underwent liquid biopsy, which consisted of blood sampling and analysis of circulating tumor cells (CTCs) and extracellular vesicles (EVs), including cell fragments and microparticles (MPs), using the Cell Search System (Menarini Silicon Biosystems). SUV, DWI, and ADC were calculated during PET-MRI, and several parameters were evaluated during CT-perfusion, including average perfusion, blood flow (BF), blood volume (BV), mean transit time (MTT), permeability-surface area product (PS), contrast extraction efficiency (E), and K-trans (K). Changes observed pre- and post-neoadjuvant therapy in each modality were compared to tumor response at histopathology using a modified Ryan tumor regression grading system.
RESULTS: Of the 17 patients included in the study, 14 were classified as non-responders, and 3 were classified as responders as determined by the modified Ryan Tumor Regression Grade (TRG) scoring system (Van der broek et al. in Dis Colon Rectum 60(3):274-283, 2017). When combined, blood markers and CT-P parameters (mean transit time (MTT), K-trans, and permeability-surface area product (PS)) produced the strongest models (p < 0.01). PET (SUV measurement) combined with CT-P-derived K-trans produced a marginally significant (p = 0.057) model for predicting response. MRI-derived ADC value did not provide a significant model for response prediction.
CONCLUSION: A model of CT-P parameters plus liquid biopsy more accurately predicts tumor response than PET-MRI, CT-P alone, or liquid biopsy alone. These results suggest that in the evaluation of treatment response, liquid biopsy could provide additional information to functional imaging modalities such as CT-P and should therefore be explored further in a trial with larger sample size.
引用
- Kassam Z, Burgers K, Walsh JC, et al. A prospective feasibility study evaluating the role of multimodality imaging and liquid biopsy for response assessment in locally advanced rectal carcinoma. Abdom Radiol (NY). 2019. PMID: 31327041. doi:10.1007/s00261-019-02135-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。